2023-04-242024-03-312024-03-31false14823671IZRO LTD2024-08-23iso4217:GBPxbrli:pure148236712023-04-24148236712024-03-31148236712023-04-242024-03-31148236712023-04-23148236712023-04-23148236712023-04-232023-04-2314823671bus:SmallEntities2023-04-242024-03-3114823671bus:AuditExempt-NoAccountantsReport2023-04-242024-03-3114823671bus:FullAccounts2023-04-242024-03-3114823671bus:PrivateLimitedCompanyLtd2023-04-242024-03-3114823671core:WithinOneYear2024-03-3114823671core:AfterOneYear2024-03-3114823671core:WithinOneYear2023-04-2314823671core:AfterOneYear2023-04-2314823671core:ShareCapital2024-03-3114823671core:SharePremium2024-03-3114823671core:RevaluationReserve2024-03-3114823671core:OtherReservesSubtotal2024-03-3114823671core:RetainedEarningsAccumulatedLosses2024-03-3114823671core:ShareCapital2023-04-2314823671core:SharePremium2023-04-2314823671core:RevaluationReserve2023-04-2314823671core:OtherReservesSubtotal2023-04-2314823671core:RetainedEarningsAccumulatedLosses2023-04-2314823671core:LandBuildings2024-03-3114823671core:PlantMachinery2024-03-3114823671core:Vehicles2024-03-3114823671core:FurnitureFittings2024-03-3114823671core:OfficeEquipment2024-03-3114823671core:NetGoodwill2024-03-3114823671core:IntangibleAssetsOtherThanGoodwill2024-03-3114823671core:ListedExchangeTraded2024-03-3114823671core:UnlistedNon-exchangeTraded2024-03-3114823671core:LandBuildings2023-04-2314823671core:PlantMachinery2023-04-2314823671core:Vehicles2023-04-2314823671core:FurnitureFittings2023-04-2314823671core:OfficeEquipment2023-04-2314823671core:NetGoodwill2023-04-2314823671core:IntangibleAssetsOtherThanGoodwill2023-04-2314823671core:ListedExchangeTraded2023-04-2314823671core:UnlistedNon-exchangeTraded2023-04-2314823671core:LandBuildings2023-04-242024-03-3114823671core:PlantMachinery2023-04-242024-03-3114823671core:Vehicles2023-04-242024-03-3114823671core:FurnitureFittings2023-04-242024-03-3114823671core:OfficeEquipment2023-04-242024-03-3114823671core:NetGoodwill2023-04-242024-03-3114823671core:IntangibleAssetsOtherThanGoodwill2023-04-242024-03-3114823671core:ListedExchangeTraded2023-04-242024-03-3114823671core:UnlistedNon-exchangeTraded2023-04-242024-03-3114823671core:MoreThanFiveYears2023-04-242024-03-3114823671core:Non-currentFinancialInstruments2024-03-3114823671core:Non-currentFinancialInstruments2023-04-2314823671dpl:CostSales2023-04-242024-03-3114823671dpl:DistributionCosts2023-04-242024-03-3114823671core:LandBuildings2023-04-242024-03-3114823671core:PlantMachinery2023-04-242024-03-3114823671core:Vehicles2023-04-242024-03-3114823671core:FurnitureFittings2023-04-242024-03-3114823671core:OfficeEquipment2023-04-242024-03-3114823671dpl:AdministrativeExpenses2023-04-242024-03-3114823671core:NetGoodwill2023-04-242024-03-3114823671core:IntangibleAssetsOtherThanGoodwill2023-04-242024-03-3114823671dpl:GroupUndertakings2023-04-242024-03-3114823671dpl:ParticipatingInterests2023-04-242024-03-3114823671dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-242024-03-3114823671core:ListedExchangeTraded2023-04-242024-03-3114823671dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-242024-03-3114823671core:UnlistedNon-exchangeTraded2023-04-242024-03-3114823671dpl:CostSales2023-04-232023-04-2314823671dpl:DistributionCosts2023-04-232023-04-2314823671core:LandBuildings2023-04-232023-04-2314823671core:PlantMachinery2023-04-232023-04-2314823671core:Vehicles2023-04-232023-04-2314823671core:FurnitureFittings2023-04-232023-04-2314823671core:OfficeEquipment2023-04-232023-04-2314823671dpl:AdministrativeExpenses2023-04-232023-04-2314823671core:NetGoodwill2023-04-232023-04-2314823671core:IntangibleAssetsOtherThanGoodwill2023-04-232023-04-2314823671dpl:GroupUndertakings2023-04-232023-04-2314823671dpl:ParticipatingInterests2023-04-232023-04-2314823671dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-232023-04-2314823671core:ListedExchangeTraded2023-04-232023-04-2314823671dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-232023-04-2314823671core:UnlistedNon-exchangeTraded2023-04-232023-04-2314823671core:NetGoodwill2024-03-3114823671core:IntangibleAssetsOtherThanGoodwill2024-03-3114823671core:LandBuildings2024-03-3114823671core:PlantMachinery2024-03-3114823671core:Vehicles2024-03-3114823671core:FurnitureFittings2024-03-3114823671core:OfficeEquipment2024-03-3114823671core:AfterOneYear2024-03-3114823671core:WithinOneYear2024-03-3114823671core:ListedExchangeTraded2024-03-3114823671core:UnlistedNon-exchangeTraded2024-03-3114823671core:ShareCapital2024-03-3114823671core:SharePremium2024-03-3114823671core:RevaluationReserve2024-03-3114823671core:OtherReservesSubtotal2024-03-3114823671core:RetainedEarningsAccumulatedLosses2024-03-3114823671core:NetGoodwill2023-04-2314823671core:IntangibleAssetsOtherThanGoodwill2023-04-2314823671core:LandBuildings2023-04-2314823671core:PlantMachinery2023-04-2314823671core:Vehicles2023-04-2314823671core:FurnitureFittings2023-04-2314823671core:OfficeEquipment2023-04-2314823671core:AfterOneYear2023-04-2314823671core:WithinOneYear2023-04-2314823671core:ListedExchangeTraded2023-04-2314823671core:UnlistedNon-exchangeTraded2023-04-2314823671core:ShareCapital2023-04-2314823671core:SharePremium2023-04-2314823671core:RevaluationReserve2023-04-2314823671core:OtherReservesSubtotal2023-04-2314823671core:RetainedEarningsAccumulatedLosses2023-04-2314823671core:NetGoodwill2023-04-2314823671core:IntangibleAssetsOtherThanGoodwill2023-04-2314823671core:LandBuildings2023-04-2314823671core:PlantMachinery2023-04-2314823671core:Vehicles2023-04-2314823671core:FurnitureFittings2023-04-2314823671core:OfficeEquipment2023-04-2314823671core:AfterOneYear2023-04-2314823671core:WithinOneYear2023-04-2314823671core:ListedExchangeTraded2023-04-2314823671core:UnlistedNon-exchangeTraded2023-04-2314823671core:ShareCapital2023-04-2314823671core:SharePremium2023-04-2314823671core:RevaluationReserve2023-04-2314823671core:OtherReservesSubtotal2023-04-2314823671core:RetainedEarningsAccumulatedLosses2023-04-2314823671core:AfterOneYear2023-04-242024-03-3114823671core:WithinOneYear2023-04-242024-03-3114823671core:Non-currentFinancialInstrumentscore:CostValuation2023-04-242024-03-3114823671core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-242024-03-3114823671core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-242024-03-3114823671core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-242024-03-3114823671core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-242024-03-3114823671core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-242024-03-3114823671core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-242024-03-3114823671core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-242024-03-3114823671core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-242024-03-3114823671core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3114823671core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3114823671core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3114823671core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3114823671core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3114823671core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3114823671core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3114823671core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3114823671core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3114823671core:Non-currentFinancialInstrumentscore:CostValuation2023-04-2314823671core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-2314823671core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-2314823671core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-2314823671core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-2314823671core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-2314823671core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-2314823671core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-2314823671core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-2314823671bus:Director12023-04-242024-03-31

IZRO LTD

Registered Number
14823671
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2024

IZRO LTD
Company Information
for the period from 24 April 2023 to 31 March 2024

Director

HEMINGTON, Caroline Louise, Dr

Registered Address

Pfm Dental Accountancy Fulford Lodge, 1heslington Lane
Fulford
York
YO10 4HW

Registered Number

14823671 (England and Wales)
IZRO LTD
Statement of Financial Position
31 March 2024

Notes

2024

£

£

Fixed assets
Tangible assets333,118
33,118
Current assets
Debtors420,674
Cash at bank and on hand66,684
87,358
Creditors amounts falling due within one year5(49,687)
Net current assets (liabilities)37,671
Total assets less current liabilities70,789
Net assets70,789
Capital and reserves
Called up share capital3
Profit and loss account70,786
Shareholders' funds70,789
The financial statements were approved and authorised for issue by the Director on 23 August 2024, and are signed on its behalf by:
HEMINGTON, Caroline Louise, Dr
Director
Registered Company No. 14823671
IZRO LTD
Notes to the Financial Statements
for the period ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis. The directors have guaranteed the continued running of the company.
Revenue from sale of goods
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Current taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Related parties
During the year the Directors made a loan to the company. At the year end the balance of the loan was £695.02.
2.Average number of employees

2024
Average number of employees during the year1
3.Tangible fixed assets

Vehicles

Office Equipment

Total

£££
Cost or valuation
Additions36,9854,41341,398
At 31 March 2436,9854,41341,398
Depreciation and impairment
Charge for year7,3978838,280
At 31 March 247,3978838,280
Net book value
At 31 March 2429,5883,53033,118
At 23 April 23---
4.Debtors: amounts due within one year

2024

£
Trade debtors / trade receivables20,674
Total20,674
5.Creditors: amounts due within one year

2024

£
Trade creditors / trade payables645
Bank borrowings and overdrafts695
Taxation and social security48,347
Total49,687